SCHEMBL3825399

SCHEMBL3825399

CCOc1ccc(-c2cc3ccc(C)cc3cn2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.56
RAB9A P51151 6/20 0.56
CASP3 P42574 2/20 0.56
SENP7 Q9BQF6 2/20 0.56
KDM4E B2RXH2 2/20 0.49
ALDH1A1 P00352 1/20 0.49
GAA P10253 1/20 0.49
MAPT P10636 3/20 0.49
L3MBTL1 Q9Y468 1/20 0.46
TP53 P04637 1/20 0.45
SCN2A Q99250 2/20 0.45
SCN10A Q9Y5Y9 2/20 0.45
CYP11B1 P15538 2/20 0.43
CYP11B2 P19099 2/20 0.43
CYP19A1 P11511 1/20 0.43
CDC25A P30304 1/20 0.43
CDC25B P30305 1/20 0.43
CDC25C P30307 1/20 0.43
DUSP3 P51452 1/20 0.43
NQO1 P15559 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3829219 0.95 NPC1 (0.51) NPC1RAB9ACASP3SENP7KDM4E
SCHEMBL28934094 0.85 NPC1 (0.59) NPC1RAB9ACASP3SENP7TP53
SCHEMBL3824837 0.84 NPC1 (0.79) NPC1RAB9ACASP3SENP7KDM4E
SCHEMBL3825642 0.80 NPC1 (0.71) NPC1RAB9ACASP3SENP7KDM4E
SCHEMBL27992750 0.80 NPC1 (0.53) NPC1RAB9ACASP3SENP7KDM4E
SCHEMBL28289931 0.80 NPC1 (0.53) NPC1RAB9ACASP3SENP7KDM4E
SCHEMBL28963415 0.79 NPC1 (0.66) NPC1RAB9ACASP3SENP7KDM4E
SCHEMBL28044842 0.79 NPC1 (0.49) NPC1RAB9ACASP3SENP7
SCHEMBL6703629 0.78 CCR1 (0.53) NPC1RAB9AKDM4EALDH1A1GAA
SCHEMBL509297 0.77 KDM4E (0.54) NPC1RAB9AKDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2099765-A2 5, 6, OR 7-SUBSTITUTED-3-(HETERO)ARYLISOQUINOLINAMINE DERIVATIVES AS ANTITUMOR AGENTS Rexahn Pharmaceuticals, Inc. (US) 2009-09-16 EP disclosed
WO-2008063548-A2 5, 6, OR 7-SUBSTITUTED-S- (HETERO)ARYLISOQUINOLINAMINE DERIVATIVES AS ANTITUMOR AGENTS REXAHN PHARMACEUTICALS, INC. (US) 2008-05-29 WO disclosed